Hong‐Fu Li

1.7k total citations
63 papers, 1.1k citations indexed

About

Hong‐Fu Li is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Hong‐Fu Li has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 17 papers in Neurology. Recurrent topics in Hong‐Fu Li's work include Neurological diseases and metabolism (14 papers), Hereditary Neurological Disorders (11 papers) and Neurogenetic and Muscular Disorders Research (11 papers). Hong‐Fu Li is often cited by papers focused on Neurological diseases and metabolism (14 papers), Hereditary Neurological Disorders (11 papers) and Neurogenetic and Muscular Disorders Research (11 papers). Hong‐Fu Li collaborates with scholars based in China, United States and Australia. Hong‐Fu Li's co-authors include Zhi‐Ying Wu, Ni Wang, Zhi‐Qi Xiong, Jianfeng Xu, Ning Wang, Wan‐Jin Chen, Guohe Tan, Qi‐Jie Zhang, Ya‐Fang Chen and Wei Wei and has published in prestigious journals such as Nature Genetics, Brain and Neurology.

In The Last Decade

Hong‐Fu Li

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong‐Fu Li China 17 396 336 322 296 277 63 1.1k
Giovanna Vaula Italy 18 639 1.6× 241 0.7× 129 0.4× 167 0.6× 141 0.5× 36 1.2k
Andreas Puschmann Sweden 24 408 1.0× 1.0k 3.0× 185 0.6× 112 0.4× 530 1.9× 57 1.6k
Sumimasa Yamashita Japan 17 568 1.4× 103 0.3× 143 0.4× 110 0.4× 231 0.8× 53 994
Denys Chaigne France 13 952 2.4× 64 0.2× 367 1.1× 662 2.2× 653 2.4× 18 1.6k
P. Anthony Akkari Australia 18 1.1k 2.9× 658 2.0× 129 0.4× 40 0.1× 228 0.8× 46 1.8k
Stefania Battistini Italy 18 411 1.0× 543 1.6× 31 0.1× 110 0.4× 127 0.5× 51 1.0k
Antonio Petrucci Italy 20 509 1.3× 492 1.5× 81 0.3× 23 0.1× 537 1.9× 44 1.1k
Qiang Dong China 19 688 1.7× 155 0.5× 76 0.2× 33 0.1× 147 0.5× 36 1.2k
Fangfang Bi China 19 486 1.2× 528 1.6× 58 0.2× 53 0.2× 250 0.9× 51 1.3k
Masataka Ifuku Japan 19 547 1.4× 61 0.2× 83 0.3× 67 0.2× 221 0.8× 23 1.2k

Countries citing papers authored by Hong‐Fu Li

Since Specialization
Citations

This map shows the geographic impact of Hong‐Fu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Fu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Fu Li more than expected).

Fields of papers citing papers by Hong‐Fu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Fu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Fu Li. The network helps show where Hong‐Fu Li may publish in the future.

Co-authorship network of co-authors of Hong‐Fu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Fu Li. A scholar is included among the top collaborators of Hong‐Fu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Fu Li. Hong‐Fu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jiaojiao, Yulan Chen, Hao Yu, et al.. (2025). Genetic and Clinical Features of SLC2A1-Related Paroxysmal Exercise-Induced Dyskinesia. Pediatric Neurology. 170. 31–37.
2.
Xu, Feng, Yanfei Huang, Hong‐Fu Li, et al.. (2024). 20 potentially new compounds and 11 new bioactive constituents found in Smilacis Glabrae Rhizoma utilizing HPLC‐DAD‐ESI‐IT‐TOF‐MSn. Phytochemical Analysis. 35(5). 1186–1196. 3 indexed citations
4.
Chen, Yulan, et al.. (2024). Both gain- and loss-of-function variants of KCNA1 are associated with paroxysmal kinesigenic dyskinesia. Journal of genetics and genomics. 51(8). 801–810. 1 indexed citations
6.
Xu, Jiaojiao, Hong‐Fu Li, & Zhi‐Ying Wu. (2023). Paroxysmal Kinesigenic Dyskinesia: Genetics and Pathophysiological Mechanisms. Neuroscience Bulletin. 40(7). 952–962. 7 indexed citations
7.
Chen, Yulan, et al.. (2022). Novel stop‐gain RNF170 variation detected in a Chinese family with adolescent‐onset hereditary spastic paraplegia. Clinical Genetics. 103(1). 87–92. 2 indexed citations
8.
Chen, Yulan, et al.. (2022). Features Differ Between Paroxysmal Kinesigenic Dyskinesia Patients with PRRT2 and TMEM151A Variants. Movement Disorders. 37(3). 608–613. 16 indexed citations
9.
Dong, Hai‐Lin, Hao Yu, Jiaqi Li, et al.. (2021). Bi-allelic loss of function variants in COX20 gene cause autosomal recessive sensory neuronopathy. Brain. 144(8). 2457–2470. 15 indexed citations
10.
Zhang, Juan, Yongfeng Xu, Lei Wu, Hong‐Fu Li, & Zhi‐Ying Wu. (2020). Characteristic of gut microbiota in southeastern Chinese patients with neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders. 44. 102217–102217. 10 indexed citations
11.
Dong, Hai‐Lin, Jiaqi Li, Hong‐Fu Li, et al.. (2020). Genetic spectrum of MCM3AP and its relationship with phenotype of Charcot‐Marie‐Tooth disease. Journal of the Peripheral Nervous System. 25(2). 107–111. 8 indexed citations
12.
Dong, Hai‐Lin, Hao Yu, Jiaqi Li, et al.. (2019). Genetic spectrum and clinical profiles in a southeast Chinese cohort of Charcot‐Marie‐Tooth disease. Clinical Genetics. 96(5). 439–448. 23 indexed citations
13.
Li, Hong‐Fu, Liqin Yang, Dazhi Yin, et al.. (2019). Associations between neuroanatomical abnormality and motor symptoms in paroxysmal kinesigenic dyskinesia. Parkinsonism & Related Disorders. 62. 134–140. 15 indexed citations
14.
Li, Lixi, Yulan Chen, Yijun Chen, et al.. (2019). Functional study and pathogenicity classification of PRRT2 missense variants in PRRT2‐related disorders. CNS Neuroscience & Therapeutics. 26(1). 39–46. 13 indexed citations
15.
Dong, Hai‐Lin, Yang‐Tian Yan, Hong‐Fu Li, et al.. (2019). Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia. Translational Neurodegeneration. 8(1). 19–19. 35 indexed citations
16.
Chen, Sheng, Ni Wang, Xinzhen Yin, et al.. (2017). Clinical features and mutation spectrum in Chinese patients with CADASIL: A multicenter retrospective study. CNS Neuroscience & Therapeutics. 23(9). 707–716. 48 indexed citations
17.
Li, Hong‐Fu, et al.. (2016). Novel homozygous PANK2 mutation identified in a consanguineous Chinese pedigree with pantothenate kinase-associated neurodegeneration. Biomedical Reports. 5(2). 217–220. 5 indexed citations
18.
Wang, Ni, et al.. (2016). FTL mutation in a Chinese pedigree with neuroferritinopathy. Neurology Genetics. 2(3). e74–e74. 9 indexed citations
19.
Zhang, Shuzhen, Lixiang Ma, Hong‐Fu Li, et al.. (2015). Modeling Neurological Disease by Rapid Conversion of Human Urine Cells into Functional Neurons. Stem Cells International. 2016(1). 19 indexed citations
20.
Wei, Na, Yong Wang, Hong‐Fu Li, Junqing Zhang, & Yonghui Li. (2013). Chemical Constituents of the Rhizomes of Alpinia oxyphylla. Chemistry of Natural Compounds. 49(5). 934–935. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026